Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Brand profile · Biotechnology Research
ErythroSight works in Biotechnology Research, out of Acton, Australian Capital Territory. It is a partnership, and its site is clearvisionresearch.com. It holds one address on record, all in Australia. Headcount on record is 2. The record links four similar brands, most of them in Biotechnology Research.
clearvisionresearch.com LinkedIn
At ErythroSight (a spinout being incubated at ANU and Clear Vision Research), we are developing next-generation therapeutics for the treatment of retinal- and neuro-degenerations. Using Red Blood Cell Derived Extracellular Vesicles (RBC-EVs), we are developing a safe, inexpensive and personalised blood-derived product to treat Age-related Macular Degeneration (AMD), the number one cause of irreversible blindness in the developed world.
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Hiring, headcount and registry-change signals, streamed to members.
Registry-filed capital and financial indicators, standardised by TheGrid.
2 employee profiles on record · names withheld.
Names and titles are intentionally absent from this page. The source relation carries no consent record across the privacy regimes this directory spans, so it is never requested and never stored. Search engines see exactly what you see here.
Names are withheld until a consented source exists.
2 counted staff profiles at January 2026, inside the self-reported 2–10 band.
One address on record, Australia only. Primary: 131 Garran Rd, Acton, Australian Capital Territory 2601.
None linked to this brand.
Four peer profiles on record: Wild Yeast Zoo and Cytophenix.